What is CVE-2026-34323?

CVE-2026-34323 is a medium-severity vulnerability in Oracle Life_sciences_inform, classified under Improper Access Control. CVSS score: 6.3/10. Published 2026-04-21.

How severe is CVE-2026-34323?

Medium severity. CVSS v3 base score is 6.3 out of 10.

Vulnerability in Oracle Life_sciences_inform

CVE-2026-34323

Vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications (component: IDM Authentication). Supported versions that are affected are 7.0.1.0 and 7.0.1.1. Easily exploitable vulnerability allows unauthent…

EPSS: 0.002 (7.3th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 6.3 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L.

Affected products

Oracle Life_sciences_inform — versions 7.0.1.0, 7.0.1.1
Oracle Corporation Life Sciences Inform — versions 7.0.1.0, 7.0.1.1

Weakness classification (CWE)

CWE-284 — Improper Access Control

References

secalert_us@oracle.com (vendor-advisory, Vendor Advisory)

Frequently asked questions

What is CVE-2026-34323?: CVE-2026-34323 is a medium-severity vulnerability in Oracle Life_sciences_inform, classified under Improper Access Control. CVSS score: 6.3/10. Published 2026-04-21.
How severe is CVE-2026-34323?: Medium severity. CVSS v3 base score is 6.3 out of 10.